Isamu Tachibana

4PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 25, 2025
A Review of Neoadjuvant Therapy for Localized and Locally Advanced Renal Cell Carcinoma.

Qian Qin, Isamu Tachibana, Vitaly Margulis

|Sep 01, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.

Luca Antonelli, Davide Ardizzone, Isamu Tachibana

|Feb 02, 2023
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?

Isamu Tachibana, Andre Alabd, Yan Tong

|Jun 08, 2022
Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?

Isamu Tachibana, Sean Q Kern, Antoin Douglawi

Pageof 1